Tickerplace logo

Tickerplace

Corvus Pharmaceuticals, Inc. logo

CRVSCorvus Pharmaceuticals, Inc.

CRVS Stock Price, Valuation & Chart | Corvus Pharmaceuticals, Inc.

Compare
$14.200-0.07 (-0.49%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyCRVS intrinsic valueCRVS calculated fair value vs price
OverviewFinancialsDividendsRatios

CRVS Historical price chart

CRVS Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization1.19B
PE Ratio-23.28
EPS-0.61
Trading Volume619.83K
Today's High/Low14.82/13.87
Dividend Yield0.00
52 Week High/Low26.95/5.58
Shares Outstanding84.09M
CRVS Financial Statement
CRVS Analyst ratings
CRVS Analysis & performance metrics

CRVS Company profile

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product…

CRVS Management team

Management
Peter A. Thompson FACP, M.D.CTO
Co-Founder & Independent Director
Jeffrey S. Arcara
Senior Vice President & Chief Business Officer
Leiv LeaCFO
Chief Financial Officer
Richard A. Miller M.D.CEO
Co-Founder, President, Chief Executive Officer & Chairman of the Board
William Benton Jones Ph.D.
Senior Vice President of Pharmaceutical Development
Total 5 executives

CRVS Frequently asked questions

What is Corvus Pharmaceuticals, Inc. (CRVS) Stock Price?

Current stock price of Corvus Pharmaceuticals, Inc. (CRVS) stock is $14.200. The stock price is -0.49% lower in the session. The intraday range can be seen from this page. Volume of Corvus Pharmaceuticals, Inc. (CRVS) stock is 619.83K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Corvus Pharmaceuticals, Inc. (CRVS) stock price going up or down today?

The stock price of Corvus Pharmaceuticals, Inc. (CRVS) can change with earnings, company news, and overall market sentiment. Corvus Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Corvus Pharmaceuticals, Inc. stock expensive at its current price?

Whether Corvus Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CRVS on this page is -23.28. EPS on this page is -0.61. Compare those figures with peers and growth expectations before deciding if the current Corvus Pharmaceuticals, Inc. price is justified.

How has the stock price of Corvus Pharmaceuticals, Inc. (CRVS) performed historically?

Historical performance for Corvus Pharmaceuticals, Inc. (CRVS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CRVS reacted to past earnings and market events.

Should I buy Corvus Pharmaceuticals, Inc. (CRVS) stock, at this price?

Buying Corvus Pharmaceuticals, Inc. (CRVS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.